A Study for Direct Application of Drug on Oral Mucosa |
Jeong, Sung-Hee
(Department of Oral Medicine, School of Dentistry, Pusan National University)
Ok, Soo-Min (Department of Oral Medicine, School of Dentistry, Pusan National University) Huh, Joon-Young (Department of Oral Medicine, School of Dentistry, Pusan National University) Ko, Myung-Yun (Department of Oral Medicine, School of Dentistry, Pusan National University) Ahn, Yong-Woo (Department of Oral Medicine, School of Dentistry, Pusan National University) |
1 | Gupta H, Bhandari D, Sharma A. Recent trends in oral drug delivery: A review. Recent Pat Drug Deliv Formul 2009;3:162-173. DOI ScienceOn |
2 | Motlekar NA, Youan BB. The quest for non-invasive delivery of bioactive macromolecules: A focus on heparins. J Control Release 2006;113:91-101. DOI ScienceOn |
3 | Gonzalez-Mariscal L, Hernandez S, Vega J. Inventions designed to enhance drug delivery across epithelial and endothelial cells through the paracellular pathway. Recent Pat Drug Deliv Formul 2008;2:145-176. DOI ScienceOn |
4 | Audet MC, Moreau M, Koltun WD et al. Evaluation of contraceptive efficacy and cycle control of a transdermal contraceptive patch vs an oral contraceptive: A randomized controlled trial. JAMA 2001;285:2347-2354. DOI ScienceOn |
5 | Nangia A. Science and technology of bioadhesivebased targeted oral delivery systems. Pharm Technol 2008;32:100-121. |
6 | Aksungur P, Sungur A, Unal S, Iskit AB, Squier CA, Senel S. Chitosan delivery systems for the treatment of oral mucositis: In vitro and in vivo studies. J Control Release 2004;98:269-279. DOI ScienceOn |
7 | Naik A, Kalia YN, Guy RH. Transdermal drug delivery: Overcoming the skin's barrier function. Pharm Sci Technolo Today 2000;3:318-326. DOI ScienceOn |
8 | Gandhi RB, Robinson JR. Oral cavity as a site for bioadhesive drug delivery. Adv Drug Deliv Rev 1994;13:43-74. DOI ScienceOn |
9 | Squier CA. The permeability of oral mucosa. Crit Rev Oral Biol Med 1991;2:13-32. DOI |
10 | Wertz PW, Squier CA. Cellular and molecular basis of barrier function in oral epithelium. Crit Rev Ther Drug Carrier Syst 1991;8:237-269. |
11 | 심영주, 최종훈, 안형준, 권정승. 구강작열감 증후군에서 클로나제팜의 국소적 적용. 대한구강내과학회지 2009; 34:429-433. 과학기술학회마을 |
12 | Chang SL, Hofmann GA, Zhang L, Deftos LJ, Banga AK. The effect of electroporation on iontophoretic transdermal delivery of calcium regulating hormones. J Control Release 2000;66:127-133. DOI ScienceOn |
13 | Henry S, McAllister DV, Allen MG, Prausnitz MR. Microfabricated microneedles: A novel approach to transdermal drug delivery. J Pharm Sci 1999;88:948. |
14 | Hadgraft J. Passive enhancement strategies in topical and transdermal drug delivery. Int J Pharm 1999; 184:1-6. DOI ScienceOn |
15 | Tennstedt D, Lachapelle J. Allergic contact dermatitis from colophony in a nitroglycerin transdermal therapeutic system. Contact Derm 1990;23:254-255. |
16 | Madhav NV, Shakya AK, Shakya P, Singh K. Orotransmucosal drug delivery systems: A review. J Control Release 2009;140:2-11. DOI ScienceOn |
17 | Bertam G., Katzung. Katzung's Basic & Clinical Pharmacology, 2002, 대한의학서적, pp. 1-34. |
18 | Shiboski CH, Hodgson TA, Ship JA, Schiodt M. Management of salivary hypofunction during and after radiotherapy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007;103 Suppl:S66.e1-19. DOI |
19 | Gremeau-Richard C, Woda A, Navez ML et al. Topical clonazepam in stomatodynia: A randomised placebo-controlled study. Pain 2004;108:51-57. DOI ScienceOn |
20 | Zhang H, Zhang J, Streisand JB. Oral mucosal drug delivery: Clinical pharmacokinetics and therapeutic applications. Clin Pharmacokinet 2002;41:661-680. DOI ScienceOn |
21 | Slomiany BL, Murty VL, Piotrowski J, Slomiany A. Salivary mucins in oral mucosal defense. Gen Pharmacol 1996;27:761-771. DOI ScienceOn |
22 | Harris D, Robinson JR. Drug delivery via the mucous membranes of the oral cavity. J Pharm Sci 1992;81: 1-10. DOI |
23 | Rathbone MJ, Drummond BK, Tucker IG. The oral cavity as a site for systemic drug delivery. Adv Drug Deliv Rev 1994;13:1-22. DOI ScienceOn |
24 | Gandhi RB, Robinson JR. Oral cavity as a site for bioadhesive drug delivery. Adv Drug Deliv Rev 1994;13:43-74. DOI ScienceOn |
25 | Squier CA, Kremer MJ, Bruskin A, Rose A, Haley JD. Oral mucosal permeability and stability of transforming growth factor beta-3 in vitro. Pharm Res 1999;16:1557-1563. DOI ScienceOn |
26 | Ganem-Quintanar A, Falson-Rieg F, Buri P. Contribution of lipid components to the permeability barrier of oral mucosa. Eur J Pharm Biopharm 1997;44:107-120. DOI ScienceOn |
27 | Shojaei AH. Buccal mucosa as a route for systemic drug delivery: A review. J Pharm Pharm Sci 1998; 1:15-30. |
28 | Prausnitz MR, Bose VG, Langer R, Weaver JC. Electroporation of mammalian skin: A mechanism to enhance transdermal drug delivery. Proc Natl Acad Sci U S A 1993;90:10504-10508. DOI ScienceOn |
29 | Kligman AM. Skin permeability: Dermatologic aspects of transdermal drug delivery. Am Heart J 1984;108:200-206. DOI ScienceOn |
30 | Lee J, Lee SK, Choi YW. The effect of storage conditions on the permeability of porcine buccal mucosa. Arch Pharm Res 2002;25:546-549. 과학기술학회마을 DOI ScienceOn |
31 | Torres V, Lopes JC, Silva M, Soares AP. Transdermal contact dermatitis from nitroglycerin. Contact Derm 1990;23:265-265. |
32 | Guy RH. Current status and future prospects of transdermal drug delivery. Pharm Res 1996;13:1765-1769. DOI ScienceOn |
33 | 오승열. 경피약물전달. 한국피부장벽학회지 2006;8:76-82. |